Pacific Biosciences of California, Inc. (PACB) Stock Analysis — Probabli.AI
AI-powered analysis for PACB (Pacific Biosciences of California, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $1.39 · Market cap: $401.7M · AI outlook: Bullish
Pacific Biosciences of California, Inc. showcases high potential due to exceptionally strong revenue growth projection, positive earnings streaks, and strategic partnerships. While regulatory and leadership challenges may pose short-term threats, the company’s innovative edge and expanding market presence position it for significant upside over the next decade.
Probabilistic 1-Year Outlook
- Bull 60% · Neutral 30% · Bear 10%
- 1-year price estimates — P10: $1 / P50: $2 / P90: $3
- Due to the strong growth estimate and recent positive catalysts, PACB can outperform the market in the short term. However, some risks and headwinds may limit upside potential.
5-Year Outlook
- Bull 65% · Neutral 25% · Bear 10%
- 5-year price estimates — P10: $2 / P50: $5 / P90: $7
SWOT Highlights
- Strength: Exceptional revenue growth forecast.
- Strength: Strong earnings beat streak.
- Risk: Recent regulatory scrutiny.
- Risk: Potential impact of leadership changes.
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
5 Wall Street analysts rate PACB a BUY with a mean price target of $2.1.
Last analyzed · Model: gpt-4o. How this forecast works · Accuracy & validation.
PACB forecast details · PACB sentiment details
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.